clinical trial · NCT04146051

Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)

$RNAC →·phase2·active not recruiting·n = 30

Myasthenia Gravis, GeneralizedDescartes-08

brief summary

This is a Phase IIb study to evaluate the safety and preliminary efficacy of Descartes-08 CAR T-cells in patients with Generalized Myasthenia Gravis

started

Dec 4, 2019

primary completion

Jul 31, 2025

completion

Mar 31, 2026

last updated

May 28, 2025

official title

Autologous T-Cells Expressing A Chimeric Antigen Receptor Directed To B-Cell Maturation Antigen (BCMA) In Patients With Generalized Myasthenia Gravis (MG)

full record on clinicaltrials.gov ↗

sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol